A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children ...

He came to celebrate the commemorative plaque presentation the Alliance of Monterey Area Preservationists (AMAP) provided to the Monterey County Board of Supervisors for the old jail, where Cesar ...

But I have a message for for Mike Johnson as to where they should place the plaque. And I think that it would be a perfect uh, presentation if the plaque was shoved up his ass. JIM ACOSTA ...

She was fully invested in her life’s work. She loved the people she did it for, and with.” Nickerson then announced the presentation of a plaque, designed by Taylor’s friend and Shepherdstown resident ...

Mary Truitt, past president, and Kevin Limestall, current board president, presented the plaques to various sites in Effingham County. “This is a long time coming. We started this project many ...

1.4%; P = .015), Budoff said during a presentation. “We are always interested in the vulnerable plaque, and we thought that given [colchicine’s] anti-inflammatory properties, it might affect ...

Following the presentations, session co-moderator Amy Paller, MD, of Northwestern University in Chicago, characterized the PsA study as "incredible and so significant for an issue that we really ...

ORLANDO — Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, according to a late-breaking presentation at the American Academy ...

Efficacy and Safety of a Highly Selective Oral TYK2 Inhibitor, ICP-488, in Patients with Moderate-to-Severe Plaque Psoriasis: A Phase II, Randomized, Double-blinded, Placebo-Controlled Trial The ...